{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T07:12:50Z","timestamp":1788246770422,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100010438","name":"Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020811","name":"Instytut Chemii Bioorganicznej, Polskiej Akademii Nauk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020811","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Appl Genetics"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s13353-025-00999-9","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T07:05:18Z","timestamp":1754723118000},"page":"743-747","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic background of Richter transformation of atypical chronic lymphocytic leukemia to diffuse large B-cell lymphoma - a case study"],"prefix":"10.1007","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-8978-2365","authenticated-orcid":false,"given":"Sandra","family":"Przybysz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0209-3282","authenticated-orcid":false,"given":"Anna","family":"\u0141ojko\u2013Dankowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8351-2815","authenticated-orcid":false,"given":"Magdalena","family":"Rakoczy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8809-335X","authenticated-orcid":false,"given":"Ma\u0142gorzata","family":"Marcinkowska-Swojak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1539-4658","authenticated-orcid":false,"given":"Micha\u0142","family":"Ze\u0144czak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0494-9833","authenticated-orcid":false,"given":"Kinga","family":"Gw\u00f3\u017ad\u017a\u2013B\u0105k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9803-6877","authenticated-orcid":false,"given":"Luiza","family":"Handschuh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0992-2020","authenticated-orcid":false,"given":"Krzysztof","family":"Lewandowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,9]]},"reference":[{"key":"999_CR1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41375-020-0797-x","volume":"35","author":"O Al-Sawaf","year":"2021","unstructured":"Al-Sawaf O, Robrecht S, Bahlo J et al (2021) Richter transformation in chronic lymphocytic leukemia (CLL)-a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials. Leukemia 35:169\u2013176. https:\/\/doi.org\/10.1038\/s41375-020-0797-x","journal-title":"Leukemia"},{"key":"999_CR2","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I et al (2022) The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia 36:1720\u20131748. https:\/\/doi.org\/10.1038\/s41375-022-01620-2","journal-title":"Leukemia"},{"key":"999_CR3","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1182\/blood.2022015851","volume":"140","author":"E Campo","year":"2022","unstructured":"Campo E, Jaffe ES, Cook JR et al (2022) The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee. Blood 140:1229\u20131253. https:\/\/doi.org\/10.1182\/blood.2022015851","journal-title":"Blood"},{"key":"999_CR4","doi-asserted-by":"publisher","unstructured":"Favini C (2020) Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia. https:\/\/doi.org\/10.20373\/uniupo\/openthesis\/114875","DOI":"10.20373\/uniupo\/openthesis\/114875"},{"key":"999_CR5","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1200\/JCO.23.02738","volume":"42","author":"PL Fedele","year":"2024","unstructured":"Fedele PL, Opat S (2024) Chronic lymphocytic leukemia: time to care for the survivors. JCO 42:2005\u20132011. https:\/\/doi.org\/10.1200\/JCO.23.02738","journal-title":"JCO"},{"key":"999_CR6","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1080\/10428194.2019.1675877","volume":"61","author":"D Filip","year":"2020","unstructured":"Filip D, Mraz M (2020) The role of MYC in the transformation and aggressiveness of \u201cindolent\u201d B-cell malignancies. Leuk Lymphoma 61:510\u2013524. https:\/\/doi.org\/10.1080\/10428194.2019.1675877","journal-title":"Leuk Lymphoma"},{"key":"999_CR7","doi-asserted-by":"publisher","first-page":"6485","DOI":"10.1074\/jbc.M113.536854","volume":"289","author":"J Han","year":"2014","unstructured":"Han J, Hou W, Goldstein LA et al (2014) A Complex between Atg7 and caspase-9: a novel mechanism of cross-regulation between autophagy and apoptosis. J Biol Chem 289:6485\u20136497. https:\/\/doi.org\/10.1074\/jbc.M113.536854","journal-title":"J Biol Chem"},{"key":"999_CR8","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adg7915","volume":"16","author":"P Iyer","year":"2024","unstructured":"Iyer P, Zhang B, Liu T et al (2024) MGA deletion leads to Richter\u2019s transformation by modulating mitochondrial OXPHOS. Sci Transl Med 16:eadg7915. https:\/\/doi.org\/10.1126\/scitranslmed.adg7915","journal-title":"Sci Transl Med"},{"key":"999_CR9","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1126\/science.1218395","volume":"336","author":"IH Lee","year":"2012","unstructured":"Lee IH, Kawai Y, Fergusson MM et al (2012) Atg7 modulates p53 activity to regulate cell cycle and survival during metabolic stress. Science 336:225\u2013228. https:\/\/doi.org\/10.1126\/science.1218395","journal-title":"Science"},{"key":"999_CR10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2113465119","volume":"119","author":"JS Long","year":"2022","unstructured":"Long JS, Kania E, McEwan DG et al (2022) ATG7 is a haploinsufficient repressor of tumor progression and promoter of metastasis. Proc Natl Acad Sci U S A 119:e2113465119. https:\/\/doi.org\/10.1073\/pnas.2113465119","journal-title":"Proc Natl Acad Sci U S A"},{"key":"999_CR11","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1038\/leu.2015.21","volume":"29","author":"FR Mauro","year":"2015","unstructured":"Mauro FR, Chauvie S, Paoloni F et al (2015) Diagnostic and prognostic role of PET\/CT in patients with chronic lymphocytic leukemia and progressive disease. Leukemia 29:1360\u20131365. https:\/\/doi.org\/10.1038\/leu.2015.21","journal-title":"Leukemia"},{"key":"999_CR12","doi-asserted-by":"publisher","first-page":"6217","DOI":"10.1158\/1078-0432.CCR-15-2903","volume":"22","author":"T Pandzic","year":"2016","unstructured":"Pandzic T, Larsson J, He L et al (2016) Transposon mutagenesis reveals fludarabine resistance mechanisms in chronic lymphocytic leukemia. Clin Cancer Res 22:6217\u20136227. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-2903","journal-title":"Clin Cancer Res"},{"key":"999_CR13","doi-asserted-by":"publisher","first-page":"4427","DOI":"10.3390\/cancers15184427","volume":"15","author":"T Robak","year":"2023","unstructured":"Robak T, Krawczy\u0144ska A, Cebula-Obrzut B et al (2023) Atypical chronic lymphocytic leukemia\u2014the current status. Cancers (Basel) 15:4427. https:\/\/doi.org\/10.3390\/cancers15184427","journal-title":"Cancers (Basel)"},{"key":"999_CR14","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1038\/s41588-022-01211-y","volume":"54","author":"P Robbe","year":"2022","unstructured":"Robbe P, Ridout KE, Vavoulis DV et al (2022) Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features. Nat Genet 54:1675\u20131689. https:\/\/doi.org\/10.1038\/s41588-022-01211-y","journal-title":"Nat Genet"},{"key":"999_CR15","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1182\/blood-2023-188550","volume":"142","author":"A Rodr\u00edguez-S\u00e1nchez","year":"2023","unstructured":"Rodr\u00edguez-S\u00e1nchez A, Quijada \u00c1lamo M, Perez Carretero C et al (2023) ZMYM3 mutations cooperate with NOTCH1 alterations, reduce histone H4 acetylation and promote apoptosis evasion in chronic lymphocytic leukemia. Blood 142:1886. https:\/\/doi.org\/10.1182\/blood-2023-188550","journal-title":"Blood"},{"key":"999_CR16","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1182\/blood-2011-12-395673","volume":"119","author":"D Rossi","year":"2012","unstructured":"Rossi D, Fangazio M, Rasi S et al (2012) Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia. Blood 119:2854\u20132862. https:\/\/doi.org\/10.1182\/blood-2011-12-395673","journal-title":"Blood"},{"key":"999_CR17","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/s41375-019-0557-y","volume":"34","author":"LD Smith","year":"2020","unstructured":"Smith LD, Minton AR, Blunt MD et al (2020) BCR signaling contributes to autophagy regulation in chronic lymphocytic leukemia. Leukemia 34:640\u2013644. https:\/\/doi.org\/10.1038\/s41375-019-0557-y","journal-title":"Leukemia"},{"key":"999_CR18","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1182\/blood.2019004492","volume":"135","author":"E Tausch","year":"2020","unstructured":"Tausch E, Schneider C, Robrecht S et al (2020) Prognostic and predictive impact of genetic markers in patients with CLL treated with obinutuzumab and venetoclax. Blood 135:2402\u20132412. https:\/\/doi.org\/10.1182\/blood.2019004492","journal-title":"Blood"},{"key":"999_CR19","doi-asserted-by":"publisher","first-page":"5426","DOI":"10.18632\/oncotarget.3101","volume":"6","author":"Y Xia","year":"2015","unstructured":"Xia Y, Fan L, Wang L et al (2015) Frequencies of SF3B1, NOTCH1, MYD88, BIRC3 and IGHV mutations and TP53 disruptions in Chinese with chronic lymphocytic leukemia: disparities with Europeans. Oncotarget 6:5426\u20135434. https:\/\/doi.org\/10.18632\/oncotarget.3101","journal-title":"Oncotarget"},{"key":"999_CR20","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12938-021-00973-6","volume":"21","author":"Y Yao","year":"2022","unstructured":"Yao Y, Lin X, Li F et al (2022) The global burden and attributable risk factors of chronic lymphocytic leukemia in 204 countries and territories from 1990 to 2019: analysis based on the global burden of disease study 2019. Biomed Eng Online 21:4. https:\/\/doi.org\/10.1186\/s12938-021-00973-6","journal-title":"Biomed Eng Online"}],"container-title":["Journal of Applied Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13353-025-00999-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13353-025-00999-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13353-025-00999-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:13:22Z","timestamp":1788243202000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13353-025-00999-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,9]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["999"],"URL":"https:\/\/doi.org\/10.1007\/s13353-025-00999-9","relation":{},"ISSN":["1234-1983","2190-3883"],"issn-type":[{"value":"1234-1983","type":"print"},{"value":"2190-3883","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,9]]},"assertion":[{"value":"12 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The local Bioethical Committee approved the study (Resolution KB 316\/24).","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from the patient included in the study.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}